Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
grade C 122.86 1.81% 2.18
BLUE closed up 4.28 percent on Tuesday, January 15, 2019, on 72 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical BLUE trend table...

Date Alert Name Type % Chg
Jan 15 Pocket Pivot Bullish Swing Setup 1.81%
Jan 15 Multiple of Ten Bullish Other 1.81%
Jan 15 Wide Bands Range Expansion 1.81%
Jan 15 Overbought Stochastic Strength 1.81%
Jan 14 50 DMA Support Bullish 6.16%
Jan 14 Pocket Pivot Bullish Swing Setup 6.16%
Jan 14 Upper Bollinger Band Walk Strength 6.16%
Jan 14 Wide Bands Range Expansion 6.16%
Jan 14 Overbought Stochastic Strength 6.16%
Jan 11 Shooting Star Candlestick Bearish 6.58%

Older signals for BLUE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Is BLUE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 236.17
52 Week Low 87.49
Average Volume 765,168
200-Day Moving Average 149.408
50-Day Moving Average 113.597
20-Day Moving Average 104.622
10-Day Moving Average 111.204
Average True Range 6.6024
ADX 22.12
+DI 26.2381
-DI 15.4594
Chandelier Exit (Long, 3 ATRs ) 100.9128
Chandelier Exit (Short, 3 ATRs ) 107.29719999999999
Upper Bollinger Band 121.9407
Lower Bollinger Band 87.3033
Percent B (%b) 0.96
BandWidth 33.107186
MACD Line 1.833
MACD Signal Line -0.9766
MACD Histogram 2.8096
Fundamentals Value
Market Cap 5.5 Billion
Num Shares 45.6 Million
EPS -7.33
Price-to-Earnings (P/E) Ratio -16.46
Price-to-Sales 233.66
Price-to-Book 5.18
PEG Ratio 0.31
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 130.76
Resistance 3 (R3) 129.65 125.19 129.08
Resistance 2 (R2) 125.19 122.62 125.74 128.52
Resistance 1 (R1) 122.93 121.03 124.06 124.04 127.96
Pivot Point 118.47 118.47 119.03 119.02 118.47
Support 1 (S1) 116.21 115.90 117.34 117.32 113.40
Support 2 (S2) 111.75 114.31 112.30 112.84
Support 3 (S3) 109.49 111.75 112.28
Support 4 (S4) 110.60